Literature DB >> 26224569

Original antigenic sin with human bocaviruses 1-4.

Xuemeng Li1,2, Kalle Kantola2, Lea Hedman2,3, Benedict Arku2, Klaus Hedman2,3, Maria Söderlund-Venermo2.   

Abstract

Human bocavirus (HBoV) 1 is a widespread parvovirus causing acute respiratory disease in young children. In contrast, HBoV2 occurs in the gastrointestinal tract and is potentially associated with gastroenteritis, whilst HBoV3 and -4 infections are less frequent and have not yet been linked with human disease. Due to HBoV1 DNA persistence in the nasopharynx, serology has been advocated as a better alternative for diagnosing acute infections. In constitutionally healthy children, we previously noted that pre-existing HBoV2 immunity in a subsequent HBoV1 infection typically resulted in low or non-existent HBoV1-specific antibody responses. A phenomenon describing such immunological events among related viruses has been known since the 1950s as 'original antigenic sin' (OAS). The aim of this study was to characterize this putative OAS phenomenon in a more controlled setting. Follow-up sera of 10 rabbit pairs, inoculated twice with HBoV1-4 virus-like particles (VLPs) or control antigens, in various combinations, were analysed with HBoV1-4 IgG enzyme immunoassays with and without depletion of heterotypic HBoV antibodies. There were no significant IgG boosts after the second inoculation in either the heterologously or the homologously HBoV-inoculated rabbits, but a clear increase in cross-reactivity was seen with time. We could, however, distinguish a distinct OAS pattern from plain cross-reactivity: half of the heterologously inoculated rabbits showed IgG patterns representative of the OAS hypothesis, in line with our prior results with naturally infected children. HBoVs are the first parvoviruses to show the possible existence of OAS. Our findings provide new information on HBoV1-4 immunity and emphasize the complexity of human bocavirus diagnosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26224569     DOI: 10.1099/jgv.0.000253

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Mapping Antigenic Epitopes on the Human Bocavirus Capsid.

Authors:  Shweta Kailasan; Jamie Garrison; Maria Ilyas; Paul Chipman; Robert McKenna; Kalle Kantola; Maria Söderlund-Venermo; Indrė Kučinskaitė-Kodzė; Aurelija Žvirblienė; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Impact of Natural or Synthetic Singletons in the Capsid of Human Bocavirus 1 on Particle Infectivity and Immunoreactivity.

Authors:  Julia Fakhiri; Kai-Philipp Linse; Mario Mietzsch; Man Xu; Marc A Schneider; Michael Meister; Oliver Schildgen; Paul Schnitzler; Maria Soderlund-Venermo; Mavis Agbandje-McKenna; Dirk Grimm
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

Review 4.  Human bocavirus: Current knowledge and future challenges.

Authors:  Marcello Guido; Maria Rosaria Tumolo; Tiziano Verri; Alessandro Romano; Francesca Serio; Mattia De Giorgi; Antonella De Donno; Francesco Bagordo; Antonella Zizza
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

5.  Global Distribution of Human Protoparvoviruses.

Authors:  Elina Väisänen; Ushanandini Mohanraj; Paula M Kinnunen; Pikka Jokelainen; Haider Al-Hello; Ali M Barakat; Mohammadreza Sadeghi; Farid A Jalilian; Amir Majlesi; Moses Masika; Dufton Mwaengo; Omu Anzala; Eric Delwart; Olli Vapalahti; Klaus Hedman; Maria Söderlund-Venermo
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

6.  Human bocavirus is detected in human placenta and aborted tissues.

Authors:  Max Hansen; Michael Brockmann; Verena Schildgen; Oliver Schildgen
Journal:  Influenza Other Respir Viruses       Date:  2018-09-30       Impact factor: 4.380

7.  Characterization of the GBoV1 Capsid and Its Antibody Interactions.

Authors:  Jennifer Chun Yu; Mario Mietzsch; Amriti Singh; Alberto Jimenez Ybargollin; Shweta Kailasan; Paul Chipman; Nilakshee Bhattacharya; Julia Fakhiri; Dirk Grimm; Amit Kapoor; Indrė Kučinskaitė-Kodzė; Aurelija Žvirblienė; Maria Söderlund-Venermo; Robert McKenna; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2021-02-20       Impact factor: 5.818

8.  Human bocavirus 1 is a genuine pathogen for acute respiratory tract infection in pediatric patients determined by nucleic acid, antigen, and serology tests.

Authors:  Ri De; Ke-Xiang Zhang; Fang Wang; Yu-Tong Zhou; Yu Sun; Dong-Mei Chen; Ru-Nan Zhu; Qi Guo; Shuang Liu; Dong Qu; Yuan Qian; Lin-Qing Zhao
Journal:  Front Microbiol       Date:  2022-07-29       Impact factor: 6.064

9.  B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study.

Authors:  Kalle Kantola; Lea Hedman; Laura Tanner; Ville Simell; Marjaana Mäkinen; Juulia Partanen; Mohammadreza Sadeghi; Riitta Veijola; Mikael Knip; Jorma Ilonen; Heikki Hyöty; Jorma Toppari; Olli Simell; Klaus Hedman; Maria Söderlund-Venermo
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

10.  Human Protoparvovirus DNA and IgG in Children and Adults with and without Respiratory or Gastrointestinal Infections.

Authors:  Ushanandini Mohanraj; Maija Jokinen; Rajita Rayamajhi Thapa; Minna Paloniemi; Timo Vesikari; Maija Lappalainen; Eveliina Tarkka; Zaiga Nora-Krūkle; Anda Vilmane; Kim Vettenranta; Charles Mangani; Sami Oikarinen; Yue-Mei Fan; Per Ashorn; Elina Väisänen; Maria Söderlund-Venermo
Journal:  Viruses       Date:  2021-03-15       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.